Quantitative Insights secured clearance from the FDA to market its QuantX Advanced system to evaluate breast abnormalities. The computer-aided diagnosis platform comes with the QI Score and Similar Case Database Compare tools, allowing clinicians to assess similarity to a database of abnormalities with clinically documented pathology.
Quantitative Insights' computer-aided diagnosis system wins FDA clearance
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.